Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | N terminal of biotin protein ligase | 0.0816 | 0 | 0.5 |
Mycobacterium ulcerans | bifunctional protein BirA | 0.1837 | 0.9245 | 0.5 |
Echinococcus multilocularis | biotin protein ligase | 0.09 | 0.0755 | 1 |
Chlamydia trachomatis | biotin synthetase | 0.09 | 0.0755 | 1 |
Entamoeba histolytica | biotin--acetyl-CoA-carboxylase ligase, putative | 0.09 | 0.0755 | 1 |
Leishmania major | biotin/lipoate protein ligase-like protein | 0.09 | 0.0755 | 0.5 |
Schistosoma mansoni | biotin-protein ligase | 0.09 | 0.0755 | 1 |
Trypanosoma cruzi | Biotin--acetyl-CoA-carboxylase ligase, putative | 0.09 | 0.0755 | 0.5 |
Plasmodium vivax | biotin--[acetyl-CoA-carboxylase] synthetase, putative | 0.09 | 0.0755 | 0.5 |
Plasmodium falciparum | biotin--acetyl-CoA-carboxylase, putative | 0.09 | 0.0755 | 0.5 |
Trypanosoma brucei | Biotin--acetyl-CoA-carboxylase ligase, putative | 0.09 | 0.0755 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.09 | 0.0755 | 0.5 |
Plasmodium falciparum | biotin protein ligase, putative | 0.09 | 0.0755 | 0.5 |
Echinococcus multilocularis | biotin protein ligase | 0.09 | 0.0755 | 1 |
Brugia malayi | biotin--acetyl-CoA-carboxylase ligase family protein | 0.09 | 0.0755 | 0.5 |
Trypanosoma cruzi | Biotin--acetyl-CoA-carboxylase ligase, putative | 0.09 | 0.0755 | 0.5 |
Echinococcus granulosus | 5'partial|biotin protein ligase | 0.0816 | 0 | 0.5 |
Treponema pallidum | biotin--acetyl-CoA-carboxylase ligase | 0.192 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | biotin-(acetyl-CoA carboxylase) ligase | 0.09 | 0.0755 | 0.5 |
Loa Loa (eye worm) | biotin protein ligase 1 | 0.09 | 0.0755 | 1 |
Mycobacterium leprae | POSSIBLE BIFUNCTIONAL PROTEIN BirA: BIOTIN OPERON REPRESSOR + BIOTIN--[ACETYL-COA-CARBOXYLASE] SYNTHETASE (BIOTIN--PROTEIN LIGAS | 0.0816 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.